Legal & Regulatory
Abbott, Mylan silent on why changing tax-inversion terms
Drugmakers Abbott Laboratories (ABT.N) and Mylan Inc (MYL.O) on Wednesday declined to explain in detail why they changed the terms of a $5.3 billion deal in which Mylan will buy part of Abbott's overseas generics business and reincorporate for tax purposes in the Netherlands.
Japan casino bill delayed again; resort opening could miss Olympics: sources
Japan's plan to open up to casino gambling has been delayed again, three people familiar with the process said, dealing a blow to one of Prime Minister Shinzo Abe's policy priorities and to hopes the first resort will open in time for the 2020 Tokyo Olympics.
Divided SEC adopts mortgage rule, decries lax lending
U.S. securities regulators adopted a rule on Wednesday designed to avert another financial crisis, but two officials dissented, saying it did not do enough to discourage banks from lending to borrowers with shaky credit and then passing the mortgage risk to investors.
Investors seek delay to HK-Shanghai stock tie-up
Some of the world's biggest banks and asset managers have asked the Hong Kong securities regulator to delay a landmark China stock trading link that could generate billions of dollars of trade a day due to uncertainty over the scheme rules, according to a letter seen by Reuters.